Latest Insider Transactions at Edwards Lifesciences Corp (EW)
This section provides a real-time view of insider transactions for Edwards Lifesciences Corp (EW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edwards Lifesciences Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edwards Lifesciences Corp's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 15
2022
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
4,000
-17.46%
|
$296,000
$74.18 P/Share
|
Nov 15
2022
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+14.86%
|
$180,000
$45.28 P/Share
|
Nov 14
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
9,500
+0.27%
|
-
|
Nov 14
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
19,875
-3.77%
|
$1,470,750
$74.76 P/Share
|
Nov 14
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
9,500
-5.21%
|
-
|
Nov 14
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,375
+13.59%
|
$1,028,125
$35.2 P/Share
|
Nov 08
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-3.46%
|
$492,456
$68.5 P/Share
|
Nov 08
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.34%
|
$260,712
$36.75 P/Share
|
Nov 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,725
-9.71%
|
$457,300
$68.46 P/Share
|
Nov 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,725
+8.85%
|
$235,375
$35.2 P/Share
|
Oct 14
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
9,500
+0.27%
|
-
|
Oct 14
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
19,875
-2.83%
|
$1,649,625
$83.93 P/Share
|
Oct 14
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
9,500
-5.24%
|
-
|
Oct 14
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,375
+13.59%
|
$1,028,125
$35.2 P/Share
|
Oct 14
2022
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
4,000
-17.46%
|
$336,000
$84.77 P/Share
|
Oct 14
2022
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+14.86%
|
$180,000
$45.28 P/Share
|
Oct 11
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-3.46%
|
$593,844
$82.12 P/Share
|
Oct 11
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.34%
|
$260,712
$36.75 P/Share
|
Oct 10
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,725
-9.71%
|
$571,625
$85.0 P/Share
|
Oct 10
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,725
+8.85%
|
$235,375
$35.2 P/Share
|
Sep 22
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
9,500
+0.28%
|
-
|
Sep 22
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
19,875
-3.77%
|
$1,669,500
$84.66 P/Share
|
Sep 22
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
9,500
-5.18%
|
-
|
Sep 22
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,375
+13.59%
|
$1,028,125
$35.2 P/Share
|
Sep 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,725
-9.71%
|
$605,250
$90.94 P/Share
|
Sep 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,725
+8.85%
|
$235,375
$35.2 P/Share
|
Sep 06
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-3.46%
|
$644,538
$89.0 P/Share
|
Sep 06
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.34%
|
$260,712
$36.75 P/Share
|
Aug 15
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
9,500
+0.28%
|
-
|
Aug 15
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
19,875
-3.77%
|
$2,067,000
$104.79 P/Share
|
Aug 15
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
9,500
-5.2%
|
-
|
Aug 15
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,375
+13.59%
|
$1,028,125
$35.2 P/Share
|
Aug 09
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-1.74%
|
$753,168
$104.81 P/Share
|
Aug 09
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.34%
|
$260,712
$36.75 P/Share
|
Aug 09
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,725
-9.71%
|
$706,125
$105.01 P/Share
|
Aug 09
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,725
+8.85%
|
$235,375
$35.2 P/Share
|
Aug 05
2022
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Direct |
4,811
-18.46%
|
$495,533
$103.66 P/Share
|
Aug 02
2022
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
1,000
-5.02%
|
$102,000
$102.49 P/Share
|
Jul 14
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
9,500
+0.28%
|
-
|
Jul 14
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
9,500
-5.69%
|
-
|
Jul 14
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
19,875
-3.68%
|
$1,888,125
$95.77 P/Share
|
Jul 14
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,375
+13.59%
|
$1,028,125
$35.2 P/Share
|
Jul 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
3,675
-3.57%
|
$356,475
$97.6 P/Share
|
Jul 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
3,675
+3.44%
|
$128,625
$35.2 P/Share
|
Jul 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,725
-9.71%
|
$652,325
$97.6 P/Share
|
Jul 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,725
+8.85%
|
$235,375
$35.2 P/Share
|
Jul 07
2022
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Grant, award, or other acquisition
|
Direct |
6,100
+3.49%
|
-
|
Jul 07
2022
|
Catherine M. Szyman CVP, Critical Care |
BUY
Grant, award, or other acquisition
|
Direct |
2,032
+5.43%
|
-
|
Jul 05
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-3.46%
|
$687,990
$95.9 P/Share
|
Jul 05
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.34%
|
$260,712
$36.75 P/Share
|